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Abstract
Background: Shoulder problems are a common complaint of the musculoskeletal system. Physical therapists treat
these patients with different modalities such as exercise, massage, and shoulder taping. Although different
techniques have been described, the effectiveness of taping has not yet been established. The aim of this study is
to assess the effectiveness and cost-effectiveness of usual physical therapy care in combination with a particular
tape technique for subacromial impingement syndrome of the shoulder compared to usual physical therapy care
without this tape technique in a primary healthcare setting.
Methods and design: An economic evaluation alongside a randomized controlled trial will be conducted. A
sample of 140 patients between 18 and 65 years of age with a diagnosis of subacromial impingement syndrome
(SAIS) as assessed by physical therapists will be recruited. Eligible patients will be randomized to either the
intervention group (usual care in combination with the particular tape technique) or the control group (usual care
without this tape technique). In both groups, usual care will consist of individualized physical therapy care. The
primary outcomes will be shoulder-specific function (the Simple Shoulder Test) and pain severity (11-point
numerical rating scale). The economic evaluation will be performed using a societal perspective. All relevant costs
will be registered using cost diaries. Utilities (Quality Adjusted Life Years) will be measured using the EuroQol. The
data will be collected at baseline, and 4, 12, and 26 weeks follow-up.
Discussion: This pragmatic study will provide information about the effectiveness and cost-effectiveness of taping
in patients presenting with clinical signs of SAIS.
Trial registration: Trial registration number: NTR2575
Background
Shoulder problems are a common complaint of the
musculoskeletal system. It is the second most common
musculoskeletal disorder following low back pain [1]
and results in high morbidity [2]. Of all shoulder pro-
blems, subacromial impingement syndrome (SAIS) is
the most frequent diagnosis [3], accounting for 44-65%
of all shoulder problems [4-6]. In general, SAIS (also
known as external impingement) is defined as the
entrapment of the rotator cuff and subacromial bursa
between the humerus and the coracoacromial arch [7].
Patients with SAIS are commonly treated by a physical
therapist (PT). Various therapeutic options have been
described, however, most are lacking a rigorous scienti-
fic background and there is uncertainty about the asso-
ciated costs [8]. Some reviews have reported that
exercise and manual treatment are most effective in
relieving pain and improving function in SAIS, but the
evidence for effectiveness is still under debate [8,9].
A promising modality in physical therapy is the appli-
cation of taping. The essential function of the tape is to
provide support during movement. However, research
indicates that the tape also plays a role in decreasing the
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stant input on the proprioceptive system of the upper
body muscles which support the active movement [11].
Three studies have examined the clinical effects of
taping patients with SAIS using leukotape in combina-
tion with fixomull stretch (BSN medical
®) [12-14]. In a
pilot study of 22 patients with unilateral shoulder pain
of more than six weeks, Miller et al. [12] compared tap-
ing as an adjunct to usual physical therapy with usual
physical therapy alone. They found a strong trend
toward reduced pain and improved function in favor of
scapular taping at two weeks. The magnitude of these
differences was reduced at a follow-up at six weeks.
Case studies of taping patients with SAIS have been
p u b l i s h e db yH o s te ta l .[ 1 3 ]a n dS h a m u sa n dS h a m u s
[14]. Both studies found a reduction in pain and an
improvement of function. In sum, the effects in pain
relief and improving shoulder function due to shoulder
taping looks promising. However, study samples were
small or had no control group. In addition, tape techni-
ques vary and we must conclude that the evidence for
its usefulness is still limited. Therefore, the primary aim
of this study is to assess the effectiveness and cost-effec-
tiveness of usual physical therapy care in combination
with one particular tape technique for subacromial
impingement syndrome of the shoulder compared to
usual physical therapy care alone in a primary health
care setting.
Methods/Design
Design
An economic evaluation will be conducted alongside a
randomized controlled trial (RCT). Figure 1 provides an
overview of the study design. Outcomes will be mea-
sured at baseline, 4, 12 and 26 weeks follow-up.
Setting
A sample of 140 patients between 18 and 65 years of
age with clinical signs of SAIS will be recruited from the
primary physical therapy setting in the Netherlands
between September 2010 and November 2011.
Ethical approval
The Medical Ethics Committee of the VU University
Medical Centre in Amsterdam has approved the study
protocol (registration number: 2010\119).
Study population
To be eligible for the trial, patients must meet the fol-
lowing criteria as assessed by the participating PTs; Two
positive impingement tests indicating SAIS (see section
impingement tests), age between 18 and 65 years, and
accepting the consequences of participation in the
study. Patients will be excluded if they have a primary
SAIS (anatomical abnormalities as scapulohumeral joint
dysplasia, total cuff tear etc. confirmed with radiography
and/or diagnostic ultrasound with exception of calcifica-
tions, minor arthrosis, and partial cuff tears]), been
operated previously at the shoulder or cervical spine, a
rheumatic disease such as polymyalgia rheumatica, rheu-
matoid arthritis, lupus erythematosis and fibromyalgia, a
severe arthritis of the glenohumeral joint, had three or
more subacromial corticosteroid injections in the last
year, a (suspected) severe disease such as malignancy,
had severe trauma of the shoulder in the last 6 months,
a neurologic disease with negative consequences for the
shoulder (such as cerebral vascular accident, multiple
sclerosis, Parkinson’s disease), type II diabetes, had a
luxation or fracture of the affected shoulder, a cervico-
radicular syndrome, a pathology of organs with negative
consequences for the shoulder, dementia, a psychiatric
disease, an insufficient understanding of the Dutch lan-
guage, a bad condition of the skin around the shoulder
because of a skin disease, and an allergy to tape.
Recruitment of patients
At the first consult, PTs will inform all eligible patients
who attend their primary care clinic about the study and
will assess patients for the in- and exclusion criteria.
Patients will be further instructed about the study through
a patient information letter. For patients interested in par-
ticipating, the PT will provide contact details of the
patients to the investigators. One of the investigators will
phone the patient before the second consult to answer
potential questions and to provide information. If the
patient decides to participate, they will be asked to fill in
baseline questionnaires (digital or paper) before the second
physical therapy consult. At the second consult, the
patient will sign an informed consent form. Thereafter,
the PT will open a numbered opaque sealed envelope con-
taining the treatment allocation (i.e. usual physical therapy
care in combination with one particular tape technique or
usual physical therapy care without this tape technique).
Treatment allocation
Prior to the study, every practice will receive 10 to 20
concealed envelopes, which contain an allocation to one
of the two treatment strategies. The randomization pro-
cess will be generated by computer. To prevent unequal
treatment-group sizes, the patients will be randomized
according to a stratified block randomization method, in
blocks of four. The PTs will not know the sequence of
the treatment allocation codes of each practice to guar-
antee allocation concealment.
Impingement tests
Many different diagnostic criteria for the SAIS have
been suggested [15]. In general, clinicians base the
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cific signs and symptoms. Research findings suggest that
single tests have limited use in informing diagnosis and
a combination of tests improves clinical utility [9,15].
For the present study, two or more positive well-known
SAIS tests will indicate a SAIS, which is in concordance
with previous pragmatic studies [16]. The following
SAIS tests will be used: the painful arc of abduction test
[17], the empty can test (Jobe test) [18], the external
rotation resistance test [19] and the Hawkins-Kennedy
test [20]. The reliability of all tests is acceptable for clin-
ical use [15].
Physical therapists
All patients will be treated by PTs of the participating
clinics. Prior to the study, all PTs will follow a 1½-hour
training session in which the rationale of the study will
be described and discussed, and the taping method will
be instructed and trained. The PTs will receive a
detailed manual of the study protocol including a stan-
dardized eligibility checklist, and a description of the
impingement tests and the taping technique.
Tape method
Patients who are allocated to usual physical therapy in
combination with tape will be treated at the end of each
treatment session for at least 4 weeks by a modified
tape technique after Shamus and Shamus [14]. In this
technique, the arm of the patient lays on the treatment
table, with the shoulder in 80° abduction in the plane of
t h es c a p u l a( F i g u r e2 ) .T w os t r i p so fr i g i dt a p e( l e u k o -
tape, BSN medical
®) will be placed upon two strips of
 
First consult; Patient with shoulder 
problems presenting in physical 
therapy practice  
Examination by the physical therapist 
Patient meets the inclusion criteria 
Patient does not 
meet the inclusion 
criteria 
Physical therapist informs 
patient about the study and 
checks interest  
Excluded 
Second consult; Patient signs 
informed consent and completes 
baseline questionnaires 
Excluded if no 
consent is given  
Usual physical therapy care in 
combination with tape (n = 70) 
Usual physical therapy care (n = 70) 
Follow-up measurements at 4, 12 and 26 
weeks 
Investigator informs the 
general practitioner of 
the patient  
Randomization (n = 140) 
Physical therapist 
informs the investigator 
Figure 1 Design of the study.
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®) without ten-
sion. When the arm of the patient is brought back to a
relaxed position along the body, the arm will be slightly
abducted from the body (approximately 10°) due to the
tension of the tape (Figure 3). The tape will be worn for a
minimum of 2 and a maximum of 7 days. Tape will be
worn for short periods (2-3 days) for patients with severe
pain and at the beginning of the tape period, and longer
for patients with less pain and who are familiar with
wearing the tape. In addition, patients with severe pain
will be taped with the shoulder in less abduction (50-70°)
so that the tape produces less tension when the arm is in
the relaxed position. At least one to two days before the
next treatment, the tape will be removed by the patient
in order to let the skin recover from the tape. The PT is
free to determine the abduction angle of the shoulder in
which the shoulder will be taped, the exact days the tape
will be worn and the number of treatments per week in
order to reflect clinical practice. During the first 4 weeks,
the treatment with tape will be stopped if the patient is
free of pain, allergic to tape or reports a substantial
increase in complaints because of the tape.
Usual care
Usual care will consist of individualized tailored physical
therapy. The content of treatment, i.e. the choice of
interventions, is at the discretion of the PT. In general,
therapy is expected to include exercises to improve
mobility and muscle function, passive mobilizations,
instructions (posture and movement), massages and ice
packages [8]. Furthermore, if the patient is not allocated
to usual care in combination with shoulder taping, the
use of kinesiotape will be allowed. In the Netherlands,
kinesiotape is frequently used, but the theoretical con-
cept, the tape structure, and the techniques are not
comparable to the tape and tape technique used in this
study [21,22]. During the first four weeks the patients
are requested not to receive any co-interventions (such
as complementary and/or alternative medicine [CAM],
injection therapy or surgery). The use of (pain) medica-
tion is allowed in both groups.
For both interventions the number of treatment ses-
sions, the treatment modalities, the treatment goals, any
deviations from the protocol, and reasons for prema-
turely terminating treatment (e.g. skin problems due to
the tape) will be recorded. In addition, PTs in both
groups familiar with the classification system described
in Cools and Walravens [23] will classify the patients
according to this system, in order to identify subgroups
that respond best to the tape technique used. The prin-
cipal investigators will regularly monitor the PTs for
compliance with the treatment protocols, by means of
phone calls and e-mail contact.
Data collection
At baseline, patients will be asked to fill in digital or paper
questionnaires before the start of the treatment, and after
4 and 26 weeks follow-up. After 12 weeks, patients will be
Figure 2 The tape is applied to the shoulder in 80° abduction
and 30° forward flexion.
Figure 3 In a relaxed position, the arm hangs in slight
abduction due to the tension of the tape.
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ceived recovery, pain severity, and costs (Table 1).
The baseline questionnaire will include questions about
socio-demographic characteristics (e.g. age, gender, and
marital status), pain severity, shoulder-specific function,
primary functional problem, health related quality of life
and general health. General health will be evaluated with
the Short-Form 36 (SF-36) [24]. This questionnaire con-
sists of 36 questions that can be aggregated to form eight
subscales (physical functioning, mental health, general
health perceptions, pain, role limitations physical, role lim-
itations emotional, social functioning, and vitality) and two
sum scales (physical and mental component scales). The
scores on all subscales range from 0-100, with higher
scores indicating better outcomes. It is a widely used mea-
surement instrument with satisfactory validity, reproduci-
bility and responsiveness to change [25]. The Dutch
translation has been found to be sufficiently valid [26].
Outcome measures
The primary outcome measures will be:
The Simple Shoulder Test (SST) [27] measuring
shoulder function. The SST will measure gains and
losses of function over time through a series of 12 ques-
tions with dichotomous “yes” or “no” response options.
More scores on yes relates to less pain and less disability
of the shoulder. The SST has been found to be suffi-
ciently valid, reliable and responsive [28,29].
The numerical rating scale (NRS) measuring pain
severity. The NRS (0 = no pain to 10 = worst imagin-
able pain) is well-accepted in clinical research with good
validity and reliability [30-32].
Secondary outcome measures include:
Global perceived recovery, measured by self-assess-
ment on a 7-point Likert scale ranging from “completely
recovered to “worse than ever” [33]. This will be dichot-
omized into success (complete and much recovered)
and non-success (slightly recovered, no change, slightly
worse, much worse, and worse than ever).
Perceived recovery from a primary functional pro-
blem, measured by an 11-point NRS. Prior to the
treatment programme, the patients will select one
functional activity that often occurs and cannot be
avoided. The patient will be asked to describe the
activity as specific as possible and wherever possible to
quantify the activity in terms of time, distance, weight
lifted, and so on. Beurskens et al. investigated the
value of this instrument in patients with low back
pain, but used a more complex procedure compared to
our pragmatic approach [34]. They concluded that the
responsiveness is good and changes in function pro-
blems were displayed properly.
Blinding
The treating PTs and patients cannot be blinded for
the treatment allocation because of the knowledge of
receiving the modality. The investigators, who will
conduct the data collection and data entry, will not be
blinded. However, almost all outcome measures will
be collected using questionnaires without personal
contact with the patient. The participating statistician
will perform the analyses blinded for treatment
allocation.
Sample size
Power calculations, based on the studies carried out by
Santamato et al. [35] and Tashjian et al. [36] were per-
formed for the 2 main outcomes (power 0.95; alpha
0.05). To detect a clinically relevant mean difference
between the two treatment groups of 2 points on the
SST [36] (standard deviation [SD] 2), 26 patients are
needed per group. To detect a clinically relevant mean
difference of 2 points (SD 3) for pain (11-point NRS)
[35], 2 groups of 59 patients are needed. Anticipating a
Table 1 Overview of data collection
Primary outcomes
Shoulder-specific function Simple Shoulder Test Baseline, 4 and 26 weeks
Pain severity 11-point numerical rating scale Baseline, 4, 12 and 26 weeks
Secondary outcomes
Global perceived recovery 7-point Likert scale 4, 12 and 26 weeks
Primary functional problem 11-point numerical rating scale Baseline, 4 and 26 weeks
Economic evaluation
Costs Cost diary 4, 12 and 26 weeks
Health related quality of life EuroQol Baseline, 4 and 26 weeks
Other
Demographic data Questionnaire Baseline
General health Short-form 36 Baseline
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group (total n = 140) will be recruited.
Data-analysis
Baseline characteristics of the two treatment groups will
be compared regarding the main prognostic characteris-
tics. The primary analysis will be on an intention-to-
treat basis. The data will be analyzed in a linear mixed
model with measurements at baseline, 4, 12 and 26
weeks. In this model, the effect of the interaction is time
by treatment interaction. The included levels will be;
repeated measures (i.e. time), patient, PT, and PT prac-
tice. The treatment effects between baseline measure-
ment and follow-up will be calculated between the two
treatment groups with a 95% confidence interval. If
prognostic factors are unevenly distributed, multivariate
analysis will be used to correct for the differences
between the groups.
The influence of deviations on the treatment protocol
will be evaluated using a per protocol analysis. A devia-
tion of the protocol is defined as not receiving treatment
after allocation, withdrawal from therapy after one to
three visits and not being treated according to patient’s
treatment allocation.
Economic evaluation from a societal perspective
The economic evaluation will be conducted from a soci-
etal perspective. Both a cost-effectiveness and cost-utility
analysis will be performed. Shoulder function (SST) and
pain severity (NRS) will be primary outcomes in the
cost-effectiveness analysis. Health-related quality of life
will be measured with the EuroQol (EQ-5D) [37]. This
questionnaire assesses 5 dimensions (mobility, self-care,
usual activities, pain/discomfort and anxiety/depression)
on a 3-point scale; no problems, moderate problems and
severe problems. The questionnaire is appropriate for
estimating quality-adjusted life-years (QALYs), and can
be used for cost-utility analysis. The total score is
expressed in utilities according to the Dolan model [38].
QALYs will be calculated by multiplying the utility of a
health state by the time spent in this health state, based
on the Dutch valuation tariff [39].
Direct and indirect costs will be measured by means
of self-completed cost diaries [40]. The following costs
will be evaluated: I) health care costs (e.g. primary care,
medical specialist care, prescription of medication, and
hospitalization); II) patient costs (out-of-pocket
expenses, such as over-the-counter medication and
CAM); and III) costs of loss of productivity (work
absenteeism).
Costs will be valued according to the guidelines pub-
lished in the updated handbook for economic evaluation
in the Netherlands [41]. For paid labour, the costs will
be calculated, using both the human capital approach
and the friction cost approach. The incremental costs
from the intervention group over the usual care group
will be compared to incremental outcomes. The incre-
mental cost-effectiveness ratios (ICER) will be calculated
with the mean differences in costs and effects. To calcu-
late the mean differences in costs and to analyse the
uncertainty around the ICERs, the bias-corrected per-
centile bootstrapping method (5,000 replications) will be
used. The uncertainties around the ICERs will be pre-
sented in a cost-effectiveness plane. Finally, the prob-
ability that usual care with the particular tape technique
is cost-effective in comparison to usual care for various
thresholds decision makers are willing to pay to gain
one extra unit of effect will be presented on a cost-effec-
tiveness acceptability curve.
Discussion
Few studies have been performed evaluating the clinical
effects of taping shoulders in patients presenting clinical
signs and symptoms of SAIS, although some promising
results have been reported [12-14]. It is interesting to
note that there have been some studies for other patient
populations using leukotape in combination with fixo-
mull stretch. Peterson [42] described a taping technique
with electrical stimulation in one patient with central
cord syndrome and bilateral shoulder subluxation and
concluded that the shoulder taping along with electrical
stimulation and a rehabilitation program may have
played a role in the reduction of the patient’s shoulder
subluxation. In a RCT, the effect of shoulder taping in
98 patients with a stroke was studied [43]. They found a
non significant trend for less pain and better function in
strapped patients after 6 weeks. Finally, a number of
authors have investigated the effect of shoulder taping
on electro-activity of shoulder muscles, but their find-
ings are contradictory [10,11,44,45].
In sum, the use of shoulder taping is a promising
modality in improving outcomes on pain relief and
function improvement in those presenting to primary
physical therapy care with signs and symptoms of SAIS,
however the method has not been adequately tested.
To our knowledge this is the first RCT examining the
possible additional effect of taping using a modified
technique according to Shamus and Shamus [14] com-
pared to usual physical therapy alone in primary care
patients presenting with signs and symptoms of SAIS. In
addition, it includes the first economic evaluation on
taping for SAIS.
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